Lataa...

SRPK1 inhibition in prostate cancer: A novel anti-angiogenic treatment through modulation of VEGF alternative splicing

Prostate cancer remains one of the leading causes of cancer death in men around the world, regardless of intense research and development of novel therapies in the last 10 years. One of the new avenues that has been tested ⿿ inhibition of angiogenesis ⿿ has been disappointing so far in clinical stud...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pharmacol Res
Päätekijät: Mavrou, Athina, Oltean, Sebastian
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2016
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4876767/
https://ncbi.nlm.nih.gov/pubmed/26995304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2016.03.013
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!